Evidence map›Paper›PMID 40732754›Full record

ArticlePathogens (Basel, Switzerland)2025

From Delta to Omicron-Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland.

Maria Miklasińska-Majdanik, Emilia Morawiec, Jolanta Bratosiewicz-Wąsik, Karol Serwin, Adam Pudełko, Michał Czerwiński, Anna Bednarska-Czerwińska, Miłosz Parczewski, Tomasz J Wąsik

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria Miklasińska-MajdanikDepartment of Microbiology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.ORCID 0000-0002-8607-8866
Emilia MorawiecDepartment of Microbiology, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 40-555 Katowice, Poland.
Jolanta Bratosiewicz-WąsikDepartment of Microbiology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.ORCID 0000-0003-2909-4955
Karol SerwinDepartment of Infectious, Tropical Diseases and Acquired Immunodeficiency, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland.ORCID 0000-0002-1071-8337
Adam PudełkoGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.
Michał CzerwińskiGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.
Anna Bednarska-CzerwińskaGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.ORCID 0000-0001-9871-7082
Miłosz ParczewskiDepartment of Infectious, Tropical Diseases and Acquired Immunodeficiency, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland.ORCID 0000-0003-1869-1084
Tomasz J WąsikDepartment of Medical Microbiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.ORCID 0000-0001-6525-9767

Funding

Marshal's Office of the Silesian Voivodeship, EU funds from the Regional Operational Program of the Silesian Voivodeship UDA-RPSL.10.01.00-24-030H/20-02Medical University of Silesia PCN-1-005/K/2/IMedical University of Silesia PCN-1-142/N/1/I
6 · The paper itself

Abstract

Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in December 2019, it has evolved, leading to variants that differ in their transmissibility, severity of disease, and susceptibility to therapy. Our goal was to describe the dynamics of the emergence of SARS-CoV-2 variants among the population of the southern part of Poland (Silesia) in the period from September 2021 to August 2022. Our results showed that, like in the rest of Poland or in neighboring countries (Czech Republic, Slovakia), Delta was replaced by the Omicron BA.1 variant, isolated for the first time in December 2021, and subsequently Omicron BA.2 and its derivative subvariants acquiring further mutations. Finally, in August 2022, only the BA.5.2.26 subvariant was present in Silesia. However, we noted differences in the dynamics of emergence and spread of some Omicron subvariants compared to the rest of Poland and the neighboring countries, which may be due to differences in population density or import of the virus from other regions.

Indexed as

COVID-19SARS-CoV-2HumansMolecular EpidemiologyMutationPolandmolecular epidemiologySARS-CoV-2 variantswhole-genome sequencing

Identifiers

PMID40732754
PMCPMC12298073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.